Cargando…
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection
Approximately 10% of individuals diagnosed with Clostridium difficile infection (CDI) show the resistance to fecal microbiota transplantation (FMT), with the underlying mechanisms remaining elusive. Deciphering the intricate microbiome profile within this particular subset of FMT-refractory patients...
Autores principales: | Tian, Hongliang, Cui, Jiaqu, Ye, Chen, Zhao, Jiangman, Yang, Bo, Xu, Yue, Ji, Shushen, Wang, Le, Lv, Xiaoqiong, Ma, Chunlian, Zhou, Shailan, Li, Ning, Wang, Xinjun, Qin, Huanlong, Chen, Qiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361143/ https://www.ncbi.nlm.nih.gov/pubmed/37469017 http://dx.doi.org/10.1080/19490976.2023.2236362 |
Ejemplares similares
-
Effectiveness of FMT in recurrent Clostridium difficile infection
por: Grzesiowski, P, et al.
Publicado: (2015) -
Gut Metagenome as a Potential Diagnostic and Predictive Biomarker in Slow Transit Constipation
por: Tian, Hongliang, et al.
Publicado: (2022) -
Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
por: Youngster, Ilan, et al.
Publicado: (2016) -
Fecal Microbiota and Human Intestinal Fluid Transplantation: Methodologies and Outlook
por: Chen, Ye, et al.
Publicado: (2022) -
Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
por: Fareed, Shaaz, et al.
Publicado: (2018)